Predictors of Androgen Status Decline in Middle-Aged Men
Recruiting now
Conditions studied: Testosterone Deficiency, Androgen Deficiency, Male Hypogonadism, Late-Onset Hypogonadism
In brief
Decreased testosterone levels in middle-aged men are associated with multiple metabolic, functional and psychosocial consequences. Early identification of modifiable factors associated with reduced testosterone levels may facilitate the early identification of men at increased risk of testosterone deficiency and support preventive healthcare strategies. This population-based cross-sectional observational study aims to investigate anthropometric, functional and lifestyle-related factors associated with serum total testosterone levels in middle-aged men. Approximately 600 men aged 35-59 years residing in the Andijan region of Uzbekistan will be recruited. Participants will undergo comprehensive assessment including anthropometric measurements, functional performance tests, standardised questionnaires and laboratory determination of serum total testosterone concentrations. Anthropometric variables will include body mass index, waist circumference, hip circumference, waist-to-hip ratio and waist-to-height ratio. Functional status will be assessed using hand-grip strength, the five-times chair-stand test and the 4-m walk test. Lifestyle-related factors including physical activity, sleep quality, dietary habits, smoking, alcohol consumption and psychoemotional status will be evaluated using validated questionnaires. The study aims to identify factors associated with serum total testosterone levels and to develop a predictive model for the early identification of men at increased risk of testosterone deficiency.
Key facts
- Study ID
- NCT07476222
- Run by
- Andijan State Medical Institute
- People needed
- 600
- Starts
- 2026-06-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-07-31
Who can join
Age: 35 and older, up to 59. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Men aged 35-59 years
- Permanent residence in the Andijan region of Uzbekistan
- Ability and willingness to provide written informed consent
- Willingness to undergo clinical, anthropometric, functional and laboratory assessments
You may not qualify if…
- Previously diagnosed hypogonadism requiring testosterone replacement therapy
- Current use of testosterone preparations or other medications known to substantially affect androgen status
- Severe cardiovascular, hepatic or renal disease in the stage of decompensation
- Clinically significant urological pathology
- Severe psychiatric illness or cognitive impairment limiting study participation
- Acute infectious or inflammatory conditions at the time of assessment
Where it is running
- Andijan State Medical Institute — Andijan, Uzbekistan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.